A detailed history of Kathmere Capital Management, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Kathmere Capital Management, LLC holds 24,616 shares of JNJ stock, worth $3.82 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
24,616
Previous 15,284 61.06%
Holding current value
$3.82 Million
Previous $2.23 Million 78.64%
% of portfolio
0.39%
Previous 0.24%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$145.48 - $167.38 $1.36 Million - $1.56 Million
9,332 Added 61.06%
24,616 $3.99 Million
Q2 2024

Jul 17, 2024

BUY
$144.38 - $157.78 $386,649 - $422,534
2,678 Added 21.24%
15,284 $2.23 Million
Q2 2024

Jul 01, 2024

SELL
$144.38 - $157.78 $391,414 - $427,741
-2,711 Reduced 17.7%
12,606 $1.84 Million
Q1 2024

Apr 16, 2024

BUY
$155.22 - $162.74 $420,801 - $441,188
2,711 Added 21.51%
15,317 $2.42 Million
Q4 2023

Apr 16, 2024

SELL
$145.6 - $158.88 $474,510 - $517,789
-3,259 Reduced 20.54%
12,606 $1.98 Million
Q3 2023

Oct 11, 2023

BUY
$155.75 - $174.48 $408,532 - $457,661
2,623 Added 19.81%
15,865 $2.47 Million
Q2 2023

Jul 11, 2023

BUY
$154.35 - $166.11 $30,098 - $32,391
195 Added 1.49%
13,242 $2.19 Million
Q1 2023

Apr 20, 2023

SELL
$151.05 - $180.26 $773,829 - $923,471
-5,123 Reduced 28.19%
13,047 $2.02 Million
Q4 2022

Jan 24, 2023

SELL
$160.2 - $179.79 $35,083 - $39,374
-219 Reduced 1.19%
18,170 $0
Q4 2022

Jan 24, 2023

BUY
$160.2 - $179.79 $1.34 Million - $1.51 Million
8,385 Added 83.82%
18,389 $0
Q3 2022

Oct 11, 2022

SELL
$161.33 - $179.52 $339,438 - $377,710
-2,104 Reduced 17.38%
10,004 $1.63 Million
Q2 2022

Aug 09, 2022

BUY
$168.19 - $186.01 $240,175 - $265,622
1,428 Added 13.37%
12,108 $2.15 Million
Q1 2022

Apr 28, 2022

BUY
$158.14 - $179.59 $900,449 - $1.02 Million
5,694 Added 114.2%
10,680 $1.89 Million
Q4 2021

Jan 27, 2022

SELL
$155.93 - $173.01 $198,966 - $220,760
-1,276 Reduced 20.38%
4,986 $853,000
Q3 2021

Oct 14, 2021

BUY
$161.5 - $179.47 $173,451 - $192,750
1,074 Added 20.7%
6,262 $1.01 Million
Q2 2021

Jul 29, 2021

BUY
$159.48 - $171.07 $102,705 - $110,169
644 Added 14.17%
5,188 $855,000
Q1 2021

May 07, 2021

BUY
$153.07 - $170.48 $48,676 - $54,212
318 Added 7.52%
4,544 $747,000
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $2,742 - $3,147
20 Added 0.48%
4,226 $665,000
Q3 2020

Nov 20, 2020

SELL
$140.38 - $153.83 $457,358 - $501,178
-3,258 Reduced 43.65%
4,206 $626,000
Q3 2020

Nov 13, 2020

BUY
$140.38 - $153.83 $692,634 - $758,997
4,934 Added 195.02%
7,464 $1.1 Million
Q2 2020

Aug 05, 2020

SELL
$128.81 - $155.51 $172,476 - $208,227
-1,339 Reduced 34.61%
2,530 $356,000
Q1 2020

May 06, 2020

BUY
$111.14 - $153.99 $49,790 - $68,987
448 Added 13.1%
3,869 $507,000
Q4 2019

Feb 13, 2020

BUY
$127.5 - $146.44 $436,177 - $500,971
3,421 New
3,421 $499,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Kathmere Capital Management, LLC Portfolio

Follow Kathmere Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kathmere Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kathmere Capital Management, LLC with notifications on news.